November 19, 2013 > $2.2 Billion settlement with Johnson & Johnson
$2.2 Billion settlement with Johnson & Johnson
Submitted By CA Department of Justice
Attorney General Kamala D. Harris issued a statement on November 4, 2013 following the announcement that California joined with 45 states, the District of Columbia and the federal government in a $2.2 billion settlement with Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., over allegations of the companiesÕ unlawful marketing practices, including off-label promotion and kickbacks, to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega.
CaliforniaÕs share of the national settlement is $89 million, the largest recovery ever for California from a national civil settlement regarding atypicalÊantipsychotic drugs.
ÒMotivated by profit, these companies made false claims that jeopardized the health of CaliforniaÕs most vulnerable patients, including children and senior citizensÑand left California taxpayers with the bill,Ó said Attorney General Harris.
The Attorney GeneralÕs Bureau of Medi-Cal Fraud and Elder Abuse investigates and prosecutes claims of Medi-Cal civil and criminal fraud, as well as allegations of elder abuse, such as physical assaults or financial theft.